Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


03.10.2022

2 BMC Neurol
3 Intern Med
9 J Clin Endocrinol Metab
3 J Immunol
1 J Neuroimmunol
4 J Neurol
1 Lancet Neurol
6 Mult Scler
1 N Engl J Med
2 Neurol Clin Pract
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. GAVIRIA-CARRILLO M, Bueno-Florez SJ, Ortiz-Salas PA
    Assessment of sexual dysfunction in patients with multiple sclerosis: a perspective from neurologist.
    BMC Neurol. 2022;22:372.
    PubMed         Abstract available

  2. ASADA T, Takenoshita S, Senda M, Yamamoto K, et al
    Secondary autoimmune hypothalamitis with severe memory impairment 7 years after the onset of diabetes insipidus due to lymphocytic hypophysitis: a case report.
    BMC Neurol. 2022;22:371.
    PubMed         Abstract available


    Intern Med

  3. SUZUKI Y, Ito S, Nomura K, Matsui A, et al
    Multiple Epstein-Barr virus-associated Gastric Cancers Arising in a Patient with Autoimmune Gastritis.
    Intern Med. 2022 Sep 28. doi: 10.2169/internalmedicine.0673.
    PubMed         Abstract available

  4. HIGUCHI T, Hoshi T, Toriyama M, Nakajima A, et al
    Infrequent Thrombotic Complications in Japanese Patients with Warm Autoimmune Hemolytic Anemia.
    Intern Med. 2022 Sep 28. doi: 10.2169/internalmedicine.0541.
    PubMed         Abstract available

  5. KUROZUMI A, Okada Y, Tanaka Y
    Changes in Glucose Intolerance after Treatment with Antithyroid Drugs in Patients with Graves' Disease Using Continuous Glucose Monitoring: A Pilot Study.
    Intern Med. 2022 Sep 28. doi: 10.2169/internalmedicine.0364.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  6. KOUFAKIS T, Dhatariya KK, Kotsa K
    Potential role of ultra-fast acting insulin analogues in the treatment of diabetic ketoacidosis.
    J Clin Endocrinol Metab. 2022 May 11. pii: 6584505. doi: 10.1210.
    PubMed        

  7. DE CASTRO M, Silva Martins C
    Integrating Molecular and Metabolomic Markers in T1D Enables Precocious Interventions: Are We Getting There?
    J Clin Endocrinol Metab. 2022;107:e4240-e4241.
    PubMed        

  8. FERNANDO R, Smith TJ
    Teprotumumab divergently alters fibrocyte gene expression: Implications for thyroid-associated ophthalmopathy.
    J Clin Endocrinol Metab. 2022 Jul 9. pii: 6638970. doi: 10.1210.
    PubMed         Abstract available

  9. TATULASHVILI S, Julla JB, Sritharan N, Rezgani I, et al
    Ambulatory glucose profile according to different phases of the menstrual cycle in women living with type 1 diabetes.
    J Clin Endocrinol Metab. 2022 Jul 23. pii: 6648857. doi: 10.1210.
    PubMed         Abstract available

  10. JACOBSEN LM, Bundy BN, Ismail HM, Clements M, et al
    Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2022 Jul 26. pii: 6650147. doi: 10.1210.
    PubMed         Abstract available

  11. LUNATI ME, Fiorina P
    Antigen-based Immunotherapy Improves Glycemic Metrics and beta-Cell Function.
    J Clin Endocrinol Metab. 2022;107:e4250-e4251.
    PubMed        

  12. YOSHII H, Mita T, Katakami N, Okada Y, et al
    The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
    J Clin Endocrinol Metab. 2022;107:e3990-e4003.
    PubMed         Abstract available

  13. TANABE H, Hirai H, Saito H, Tanaka K, et al
    Detecting Sarcopenia Risk by Diabetes Clustering: A Japanese Prospective Cohort Study.
    J Clin Endocrinol Metab. 2022 Jul 31. pii: 6652583. doi: 10.1210.
    PubMed         Abstract available

  14. KAUSHAL T, Tinsley LJ, Volkening LK, Turcotte C, et al
    Improved CGM Glucometrics and More Visits in Pediatric Type 1 Diabetes using Telemedicine During 1 Year of COVID-19.
    J Clin Endocrinol Metab. 2022 Aug 11. pii: 6660713. doi: 10.1210.
    PubMed         Abstract available


    J Immunol

  15. SONG J, Anderson W, Hu A, Obata-Ninomiya K, et al
    CBLB Deficiency in Human CD4(+) T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms.
    J Immunol. 2022;209:1260-1271.
    PubMed         Abstract available

  16. GAO M, Liu S, Chatham WW, Mountz JD, et al
    IL-4-Induced Quiescence of Resting Naive B Cells Is Disrupted in Systemic Lupus Erythematosus.
    J Immunol. 2022 Sep 7. pii: jimmunol.2200409. doi: 10.4049/jimmunol.2200409.
    PubMed         Abstract available

  17. ZHANG Q, Liu Y, Liao J, Wu R, et al
    Deficiency of p53 Causes the Inadequate Expression of miR-1246 in B Cells of Systemic Lupus Erythematosus.
    J Immunol. 2022 Sep 9. pii: jimmunol.2200307. doi: 10.4049/jimmunol.2200307.
    PubMed         Abstract available


    J Neuroimmunol

  18. MAGALASHVILI D, Mandel M, Dreyer-Alster S, Didikin M, et al
    Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4.
    J Neuroimmunol. 2022;372:577966.
    PubMed         Abstract available


    J Neurol

  19. ZHANG S, Yang S, Lu J, Liu S, et al
    CIDP-like autoimmune nodopathy complicated with focal segmental glomerulosclerosis: a case study and literature review.
    J Neurol. 2022 Sep 30. pii: 10.1007/s00415-022-11369.
    PubMed         Abstract available

  20. STASCHEIT F, Grittner U, Hoffmann S, Mergenthaler P, et al
    Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
    J Neurol. 2022 Sep 27. pii: 10.1007/s00415-022-11389.
    PubMed         Abstract available

  21. MARGONI M, Pagani E, Preziosa P, Palombo M, et al
    In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis.
    J Neurol. 2022 Sep 24. pii: 10.1007/s00415-022-11386.
    PubMed         Abstract available

  22. PAGANI E, Storelli L, Pantano P, Petsas N, et al
    Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis.
    J Neurol. 2022 Sep 24. pii: 10.1007/s00415-022-11387.
    PubMed         Abstract available


    Lancet Neurol

  23. BENNETT JL, Costello F, Chen JJ, Petzold A, et al
    Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment.
    Lancet Neurol. 2022 Sep 22. pii: S1474-4422(22)00187.
    PubMed         Abstract available


    Mult Scler

  24. POL-PATIL J, Glanz B, Safar L, Misasi E, et al
    MeTooMS: Sexual, physical, and emotional abuse experience among women with multiple sclerosis.
    Mult Scler. 2022 Sep 24:13524585221122169. doi: 10.1177/13524585221122169.
    PubMed         Abstract available

  25. BRUIJSTENS AL, Stingl C, Guzel C, Stoop MP, et al
    Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood.
    Mult Scler. 2022 Sep 24:13524585221125369. doi: 10.1177/13524585221125369.
    PubMed         Abstract available

  26. SARACENO L, Pirro F, Stigliano R, Agostoni EC, et al
    Acute idiosyncratic liver injury after Cladribine treatment for multiple sclerosis: first case report and review on associated hepatic disorders.
    Mult Scler. 2022 Sep 28:13524585221125360. doi: 10.1177/13524585221125360.
    PubMed         Abstract available

  27. STRIK M, Eijlers AJ, Dekker I, Broeders TA, et al
    Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis.
    Mult Scler. 2022 Sep 30:13524585221125372. doi: 10.1177/13524585221125372.
    PubMed         Abstract available

  28. ALEXANDER S, Braisher M, Tur C, Chataway J, et al
    The mSteps pilot study: Analysis of the distance walked using a novel smartphone application in multiple sclerosis.
    Mult Scler. 2022 Sep 30:13524585221124043. doi: 10.1177/13524585221124043.
    PubMed         Abstract available

  29. BUHLER A, Wolbers M, Model F, Wang Q, et al
    Recurrent disability progression endpoints in multiple sclerosis clinical trials.
    Mult Scler. 2022 Sep 30:13524585221125382. doi: 10.1177/13524585221125382.
    PubMed         Abstract available


    N Engl J Med

  30. RUSSELL SJ, Beck RW, Damiano ER, El-Khatib FH, et al
    Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2022;387:1161-1172.
    PubMed         Abstract available


    Neurol Clin Pract

  31. WIJERATNE T, Jones EC, Grisold W, Carroll WM, et al
    Global Advocacy in Action: World Brain Day 2021 Dedicated to Stopping Multiple Sclerosis.
    Neurol Clin Pract. 2022;12:e1-e2.
    PubMed        

  32. LOPEZ RUIZ R, Sanchez Fernandez F, Ruiz de Arcos M, Dotor Garcia-Soto J, et al
    Skin Autoimmunity Secondary to Alemtuzumab in a Tertiary Care Spanish Hospital.
    Neurol Clin Pract. 2022;12:29-35.
    PubMed         Abstract available


    PLoS One

  33. ABUAF AF, Bunting SR, Klein S, Carroll T, et al
    Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.
    PLoS One. 2022;17:e0274778.
    PubMed         Abstract available

  34. ALMAZROUEI R, Sharma C, Afandi B, Aldahmani KM, et al
    Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.
    PLoS One. 2022;17:e0264545.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  35. BEHRANGI N, Heinig L, Frintrop L, Santrau E, et al
    Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.
    Proc Natl Acad Sci U S A. 2022;119:e2204509119.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: